Health Canada drug identification number

DIN 02418355 — SOVALDI 400 MG

SOVALDI is a tablet of Sofosbuvir marketed by GILEAD SCIENCES CANADA INC. The full Sofosbuvir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02418355
Brand name
SOVALDI
Active ingredient
Sofosbuvir
Strength
400 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
GILEAD SCIENCES CANADA INC
Health Canada status
MARKETED
Drug class
Direct-acting antiviral (NS5B polymerase inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.